BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2019 11:18:56 AM | Browse: 1141 | Download: 2724
 |
Received |
|
2019-10-30 16:43 |
|
Peer-Review Started |
|
2019-10-30 16:43 |
|
First Decision by Editorial Office Director |
|
2019-11-09 16:29 |
|
Return for Revision |
|
2019-11-09 16:29 |
|
Revised |
|
2019-12-01 06:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-12-06 06:30 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-12-06 22:15 |
|
Articles in Press |
|
2019-12-06 22:15 |
|
Edit the Manuscript by Language Editor |
|
2019-12-10 01:47 |
|
Typeset the Manuscript |
|
2019-12-13 06:22 |
|
Publish the Manuscript Online |
|
2019-12-14 11:18 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Two-week bismuth-containing quadruple and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-labeled randomized trial
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
So Jeong Kim, Jun-Won Chung, Hyun Sun Woo, Su Young Kim, Jung Ho Kim, Yoon Jae Kim, Kyoung Oh Kim, Kwang An Kwon and Dong Kyun Park |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jun-Won Chung, MD, PhD, Associate Professor, Division of Gastroenterology, Department of Internal Medicine, Gachon University Gil Medical Center, 21, Namdong-daero 774 beon-gil, Namdong-gu, Incheon 21565, South Korea. junwonchung@daum.net |
| Key Words |
Helicobacter pylori; Therapy; Bismuth-containing quadruple therapy; Concomitant therapy; ; |
| Core Tip |
Both bismuth-containing quadruple therapy and concomitant therapy proved to be useful empirical first-line treatment options for Helicobacter pylori eradication in an area exhibiting high-level clarithromycin-resistance (> 15%). |
| Publish Date |
2019-12-14 11:18 |
| Citation |
Kim SJ, Chung JW, Woo HS, Kim SY, Kim JH, Kim YJ, Kim KO, Kwon KA, Park DK. Two-week bismuth-containing quadruple and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-labeled randomized trial. World J Gastroenterol 2019; 25(46): 6790-6798 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i46/6790.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i46.6790 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
